longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Cafรฉ
longbridge
ยฉ 2026 Longbridge๏ฝœTerms of ServicePrivacy Policy

Viking

VIK

77.1901.46% ( -1.140 )
Trading: Oct 1, 11:10:47 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
Share your thoughts

What's on your mind?

0 / 2,000
  • S
    Sunrise TraderJul 9 at 09:21 PM

    I know some traders I follow trade the cruise lines. Some showing signs of reversing. $Norwegian Cruise(NCLH.US) $Carnival(CCL.US) $Royal Caribbean Cruises(RCL.US) $Viking(VIK.US)

    Source: Sunrise Trader

  • F
    First FellowJun 14 at 06:46 PM

    $Viking(VIK.US) is the only cruise line that excites me. There is much more upside to even catch up to the valuation of the remaining names like $Carnival(CCL.US), $Norwegian Cruise(NCLH.US) in the sector.

    ๅ›พ็‰‡ 1๏ผŒๅ…ฑ 1 ๅผ 
  • W
    What TrendSpider SayMay 14 at 11:17 AM

    $Viking(VIK.US) Just barely eked out a Double Beat

    Adj EPS: $(0.11) vs $(0.12) est

    REV: $1.054B vs $1.010B est

    ๐ŸŸฉ +2.23%

    ๅ›พ็‰‡ 1๏ผŒๅ…ฑ 1 ๅผ 
  • H
    Hardik ShahMay 12 at 11:07 AM

    ๐Ÿ“ข ๐‰๐”๐’๐“ ๐ˆ๐: $Viking Therap(VKTX.US) Viking Therapeutics Reports Phase 2 Oral VK2735 Obesity Data

    ๐Ÿ‘‰ ๐Š๐ž๐ฒ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ:

    โžค Oral ๐•๐Š๐Ÿ๐Ÿ•๐Ÿ‘๐Ÿ“ achieved up to ๐Ÿ๐Ÿ.๐Ÿ% weight loss in ๐Ÿ๐Ÿ‘ weeks.

    โžค Placebo group recorded ๐Ÿ.๐Ÿ‘% average weight reduction.

    โžค Trial enrolled ๐Ÿ๐Ÿ–๐ŸŽ adults with obesity or overweight conditions.

    โžค Weight loss began by ๐ฐ๐ž๐ž๐ค ๐Ÿ and continued without plateauing.

    โžค Up to ๐Ÿ—๐Ÿ•% of participants achieved at least ๐Ÿ“% weight loss.

    โžค Treatment targets both ๐†๐‹๐-๐Ÿ and ๐†๐ˆ๐ receptors.

    โžค Viking plans to launch ๐๐ก๐š๐ฌ๐ž ๐Ÿ‘ trials for oral VK2735 this year.